However, we know that there are thousands of ‘unsung heroes’ around the world, working in different capacities on different clinical trials to make the breakthrough. It has been a herculean collective effort. Of course, while this is a particularly high stakes situation, seeing an impact on patients’ lives motivates us no matter the therapeutic area. In this podcast, I interview Nancy Carpenter, a Principal Statistician at Veramed who has worked extensively on COVID-19 trials over the last several months. Our wide-ranging discussion covers:

• Her experience of working on COVID-19 trials
• How patient stories inspire her
• How we balance risks and manage the impact of COVID-19 on other clinical trials
• How a role in pharma provides meaning and fulfilment
• How the pandemic has increased public interest in the pharmaceutical industry

Listen to this episode now and share this to your friends and colleagues!